Transplantation of stem cells from various cell sources may represent a safe and effective therapy for multiple sclerosis (MS). However, up to now there have been no controlled studies comparing stem cell therapy and finding a consistent answer regarding the safety and efficacy of this type of therapy for people with MS large groups of people with MS.1
HSCs and MSCs are more available than NSCs, although NSCs may be able to offer superior effects with remyelination that make them more attractive for studies in clinical stages.
Find out more the latest about clinical trials for each type of stem cells:
Note: Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis, or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.